Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator

American Heart Journal

Volumn 144, Issue 3, 2002, Pages 440-448

  Owens, Douglas K ^a,b,c   Sanders, Gillian D ^b,c   Heidenreich, Paul A ^a,b   McDonald, Kathryn M ^b,c   Hlatky, Mark A ^b,c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DIAGNOSTIC TEST; DRUG USE; EVALUATION; HUMAN; META ANALYSIS; MONEY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; REGISTER; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH;

EID: 0036733447     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.125501     Document Type: Article

References (38)

1. The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death
2. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone
3. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias: The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
4. Canadian Implantable Defibrillator Study (CIDS): Study design and organization: CIDS Co-Investigators
5. Randomized comparison of anti-arrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH)
6. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators
7. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
8. A randomized study of the prevention of sudden death in patients with coronary artery disease: Multicenter Unsustained Tachycardia Trial Investigators
9. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery: Coronary Artery Bypass Graft (CABG) Patch Trial Investigators
10. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death
11. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies: Antiarrhythmics vs Implantable Defibrillator study: Cardiac Arrest Study Hamburg: Canadian Implantable Defibrillator study
12. Overview of randomized trials of antiarrhythmic drugs and devices for the prevention of sudden cardiac death
13. Cost-effectiveness of the implantable cardioverter-defibrillator: Results from the Canadian Implantable Defibrillator Study (CIDS)
14. Cost-effectiveness of the implantable cardioverter defibrillator?
15. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction
16. Risk of sudden versus non-sudden death in patients with coronary artery disease
17. Markov models in medical decision making: A practical guide
18. Adverse events with transvenous implantable cardioverter-defibrillators: A prospective multicenter study: European 7219 Jewel ICD investigators
19. Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death
20. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: Meta-analysis of individual data from 6500 patients in randomised trials
21. Cost-effectiveness of the implantable cardioverter-defibrillator: Effect of improved battery life and comparison with amiodarone therapy
22. Nonthoracotomy- versus thoracotomy-implantable defibrillators: Intention-to-treat comparison of clinical outcomes
23. Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries: 1985-1995
24. Utilization and outcomes of the implantable cardioverter defibrillator, 1987-1995
25. Utility of therapy with amiodarone or an implantable defibrillator assessed by patients at risk for sudden cardiac death
26. Medical decision making: Probabilistic medical reasoning
27. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction: ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators
28. Risk stratification of patients with ventricular arrhythmias
29. Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: The Canadian implantable defibrillator study
30. Results of the international study of the implantable pacemaker cardioverter-defibrillator
31. Long-term multicenter experience with a second generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias
32. Automatic implantable cardioverter-defibrillator: Patient survival, battery longevity and shock delivery analysis